{"ticker": {"uuid": "c6e08cf3-3bc0-460f-b661-9071ed0a5283", "symbol": "LIXT", "name": "Lixte Biotechnology Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "LIXTE to loan $6.5M to NOMAD ahead of acquisition close", "summary": "LIXTE Biotechnology Holdings, Inc. announced it will loan $6.5 million to NOMAD Transportable Power Systems prior to their acquisition closing, expected around July 1, 2026. This loan will help fund procurement and working capital for NOMAD, a company specializing in deployable b", "url": "https://www.investing.com/news/company-news/lixte-to-loan-65m-to-nomad-ahead-of-acquisition-close-93CH-4749907", "source_name": "Investing.com", "published_at": "2026-06-19T10:11:19", "published_display": "19 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026", "summary": "LIXTE Biotechnology Holdings, Inc. has provided an update on its acquisition of NOMAD Transportable Power Systems, Inc., a deal expected to close around July 1, 2026. LIXTE will loan NOMAD $6.5 million to fund its order backlog and working capital needs before closing, aiming to ", "url": "https://www.marketscreener.com/news/lixte-biotechnology-provides-update-on-nomad-acquisition-transaction-expected-to-close-on-or-about-ce7f5cdddf80f224", "source_name": "www.marketscreener.com", "published_at": "2026-06-19T10:09:12", "published_display": "19 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE loans NOMAD $6.5M before power-storage deal closes", "summary": "LIXTE Biotechnology has provided a pre-closing loan of $6.5 million to NOMAD Transportable Power Systems to fund its order backlog and working capital as the acquisition is expected to close around July 1, 2026. Upon completion, LIXTE will be renamed NOMAD Power Solutions and tra", "url": "https://www.stocktitan.net/news/LIXT/lixte-biotechnology-provides-update-on-nomad-acquisition-transaction-xq2mbfb4dp53.html", "source_name": "Stock Titan", "published_at": "2026-06-18T22:09:57", "published_display": "18 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings, Inc. (LIXTW) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1pUXFMTVFJSTBqLTVpSXJNY1pqSU9CSUFqeFRyOFkwZE80dE5VNUtJODFPWDl3OHpBYUprVDlEbnAzdE10b0std241N3VHX2JtQ0NZ?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-06-18T20:03:33+00:00", "published_display": "18 Jun 2026 20:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (NASDAQ: LIXT) funds NOMAD with $6.5M secured bridge loan", "summary": "LIXTE Biotechnology Holdings, Inc. provided NOMAD Transportable Power Systems with a $6.5 million secured bridge loan ahead of their planned acquisition, expected to close around July 1, 2026. The loan will help NOMAD repay existing debt and fund working capital to meet its activ", "url": "https://www.stocktitan.net/sec-filings/LIXT/8-k-lixte-biotechnology-holdings-inc-reports-material-event-783875ee424a.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:10:26", "published_display": "18 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Provides $6.5 Million Secured Note to NOMAD Ahead of Planned Merger", "summary": "Lixte Biotechnology has provided a $6.5 million secured promissory note to NOMAD Transportable Power Systems in anticipation of their upcoming merger. These funds will be used to repay NOMAD's existing loan and cover working capital needs. The note, secured by NOMAD's assets, has", "url": "https://www.tradingview.com/news/tradingview:e6fdf0c6e90cd:0-lixte-biotechnology-provides-6-5-million-secured-note-to-nomad-ahead-of-planned-merger/", "source_name": "TradingView", "published_at": "2026-06-18T20:10:26", "published_display": "18 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Nasdaq Company Just Reinvented Itself as a Power Company \u2014 and Bet It All on the AI Energy Crunch", "summary": "LIXTE Biotechnology Holdings (NASDAQ: LIXT) is transforming into NOMAD Power Solutions, a pure-play deployable power company, by combining with NOMAD Transportable Power Systems. This strategic shift addresses the critical electricity bottleneck facing the AI industry, with LIXTE", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314363/0/en/a-nasdaq-company-just-reinvented-itself-as-a-power-company-and-bet-it-all-on-the-ai-energy-crunch.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T15:10:26", "published_display": "18 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The AI Boom\u2019s Real Bottleneck Is Power \u2014 and One Nasdaq Company Is Reinventing Itself to Solve It", "summary": "LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) is transforming into NOMAD Power Solutions, a pure-play deployable-power company, via a merger with NOMAD Transportable Power Systems. This strategic shift aims to address the significant power demands of the AI industry, which ha", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314267/0/en/the-ai-boom-s-real-bottleneck-is-power-and-one-nasdaq-company-is-reinventing-itself-to-solve-it.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T13:10:26", "published_display": "18 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Lixte Biotechnology Holdings Inc (LIXT), including its current price momentum score, support and resistance levels. It details various technical indicators like MACD, RSI, and moving averages, offering buy, sell, or neutral signals. T", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/technical", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:26", "published_display": "18 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Institutional Confidence", "summary": "Lixte Biotechnology Holdings Inc (LIXT) has an institutional shareholding score of 3.00, placing it 193rd out of 388 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 8.14%, reflecting a 4.01% decrease quarter-over-quarter. Jame", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T06:10:04", "published_display": "18 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Lixte Biotechnology Holdings Inc (LIXT), indicating that no earnings forecast score is currently available for the company. It notes the Biotechnology & Medical Research industry's average score is 8.13 and states that relevant financ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T05:10:05", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Lixte Biotechnology Holdings Inc (LIXT), noting its current valuation score of 6.61 and its ranking within the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -6.07, and states that relevant data fo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T05:10:05", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFAzeFlLY1JSWjNDLUI5OG9yMThjZ1dKT1ZIZDZIS292cW5XUTFMaFlVZWJLQjhCTkZZWll6bmNlQzNFOE1tbUx1RHVQX0pkaVV3b1plM2tuUThVYzZsOS1GZjdma3RZTlVqVXdSVWc1VkluMEVjbmtv?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T02:20:24+00:00", "published_display": "18 Jun 2026 02:20", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5icVZSQWVLWDg3RFMzZnlMcHpraTExaF80VU1MRFpRWURYdXBnQ2JrTVV2eC1qS0Y1b21UYmVPT3h3dnV1cEtGT0xqRVFrTDNBc21qa1ExTjBZWFB4QjRqRWtxcTZxX2MtSHRlSmZEX0NOdkpWaFp5LQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:52:43+00:00", "published_display": "17 Jun 2026 21:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of dividend and stock split history for Lixte Biotechnology Holdings Inc (LIXTW). It indicates that the company has distributed a total of $0.00 in dividends over the past five years and has no recorded stock split data. The page serves as a fina", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T06:41:59", "published_display": "17 Jun 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc", "summary": "This article provides an overview of Lixte Biotechnology Holdings Inc. (LIXTW), noting that relevant data regarding its revenue breakdown by business segments and regions have not yet been disclosed by the company. The page displays the current stock price and highlights that fin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T05:40:40", "published_display": "17 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides a detailed look into the shareholder structure of Lixte Biotechnology Holdings Inc (LIXTW), focusing on institutional holdings and recent shareholder activity. It presents data on the number of institutions holding shares, the total shares held, and changes ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T05:40:40", "published_display": "17 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology to Acquire Nomad Transportable Power Systems in Stock Deal of Up to 53.5M Shares", "summary": "Lixte Biotechnology has entered into a Merger Agreement to acquire Nomad Transportable Power Systems through a stock-for-stock transaction. Nomad shareholders are set to receive up to 50.5 million common shares via Series D Convertible Preferred Stock and an additional 3.0 millio", "url": "https://www.tradingview.com/news/tradingview:f784e608344df:0-lixte-biotechnology-to-acquire-nomad-transportable-power-systems-in-stock-deal-of-up-to-53-5m-shares/", "source_name": "TradingView", "published_at": "2026-06-16T20:03:16", "published_display": "16 Jun 2026 20:03", "sentiment": "positive", "sentiment_pct": 69, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (NASDAQ: LIXT) to buy NOMAD and pivot into mobile grid-scale BESS", "summary": "LIXTE Biotechnology Holdings, Inc. has entered into a definitive merger agreement to acquire 100% of NOMAD Transportable Power Systems, a leader in mobile battery energy storage systems, and will be renamed NOMAD Power Solutions. This strategic acquisition shifts LIXTE from a cli", "url": "https://www.stocktitan.net/sec-filings/LIXT/8-k-lixte-biotechnology-holdings-inc-reports-material-event-346afb8b9eb5.html", "source_name": "Stock Titan", "published_at": "2026-06-16T19:59:16", "published_display": "16 Jun 2026 19:59", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Lixte Biotechnology Holdings Inc (LIXTW), focusing on key indicators and moving averages. It highlights that while multiple indicators suggest \"Sell\" or \"Oversold\" signals, some moving averages (MA5, MA10) show \"Buy\" signals. The arti", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/technical", "source_name": "TradingKey", "published_at": "2026-06-16T14:39:17", "published_display": "16 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Institutional Confidence", "summary": "The article provides an overview of Lixte Biotechnology Holdings Inc (LIXTW), focusing on its institutional confidence score and shareholder activity. It lists several institutional holders and the changes in their shareholdings, with many showing a 100% decrease. The institution", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T14:39:16", "published_display": "16 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The New Bottleneck Isn\u2019t Computing Power \u2014 It\u2019s Just Power", "summary": "The AI boom's new bottleneck is not computing power but the availability of electricity, as building data centers outpaces the grid's ability to deliver power. LIXTE Biotechnology Holdings, Inc. is repositioning itself to address this challenge by acquiring NOMAD Transportable Po", "url": "https://www.theglobeandmail.com/investing/markets/stocks/FLNC/pressreleases/2451956/the-new-bottleneck-isnt-computing-power-its-just-power/", "source_name": "The Globe and Mail", "published_at": "2026-06-13T07:40:56", "published_display": "13 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch", "summary": "LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT), previously a clinical-stage cancer-drug developer, is undergoing a complete corporate transformation to become a pure-play power-infrastructure company. This strategic shift involves the acquisition of NOMAD Transportable Power S", "url": "https://www.sahmcapital.com/news/content/from-cancer-drugs-to-kilowatts-a-nasdaq-companys-bet-on-the-ai-power-crunch-2026-06-12", "source_name": "Sahm", "published_at": "2026-06-12T20:41:59", "published_display": "12 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)", "summary": "", "url": "https://finance.yahoo.com/sectors/energy/articles/lixte-biotechnology-acquire-nomad-transportable-123000285.html", "source_name": "GlobeNewswire", "published_at": "2026-06-12T12:30:00+00:00", "published_display": "12 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mobile grid batteries for AI boom: LIXTE to acquire NOMAD BESS leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNc0QxM0x3TG5ZbDUzVDI5LXFmVnZyWUxGd25MZjFXWEhDWmtpdEUxYURfOWJEZ1VWVEhhVHVKR3EwNTA5QzZFcUtFdHZ0VDJTNi1iQU4zVHpNVW84d045YlliQkp1cTYyWDdicnAxVGdjY1h4d0RCSUs1cUdNZEFMMGgybkQtSXg4V2swZFF5SjBFNk9TczNLUHE2bGpLWE1hXzhrYmFlb2doZTVSWm5oOWVTWi04SmxfWWcyMlg5NWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T12:30:00+00:00", "published_display": "12 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE to acquire NOMAD Transportable Power Systems for BESS pivot", "summary": "LIXTE Biotechnology (NASDAQ:LIXT) is strategically transforming its business by acquiring NOMAD Transportable Power Systems. This acquisition marks a pivot from its oncology pipeline to become a platform for AI and utility energy infrastructure, addressing critical bottlenecks in", "url": "https://grafa.com/en/news/united-states/lixte-biotechnology-nomad-power-acquisition", "source_name": "grafa.com", "published_at": "2026-06-12T08:09:10", "published_display": "12 Jun 2026 08:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G] LIXTE BIOTECHNOLOGY HOLDINGS, INC. Passive Investment Disclosure (>5%)", "summary": "This SEC filing (Schedule 13G) discloses that Strategic EP, LLC and Alexander Chase Deitch have acquired beneficial ownership of 5.1% of LIXTE BIOTECHNOLOGY HOLDINGS, INC. common stock. The filing states that Strategic EP, LLC and Alexander Chase Deitch collectively own 774,902 s", "url": "https://www.stocktitan.net/sec-filings/LIXT/schedule-13g-lixte-biotechnology-holdings-inc-passive-investment-disc-14e8ee164895.html", "source_name": "Stock Titan", "published_at": "2026-06-09T23:40:18", "published_display": "09 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology (NASDAQ:LIXT) holders report 5.1% stake in company", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOVEswMzZvV3FDVllWS1ZhbDNHX2N5bTh6cmRieXM5R3pKNDI2WWpvRnI4MlNyckwyVTk1bE1ySXdWYVN0S1NrRkVPek5zbDBHUmd0ajUwNXlvZ1JRMG91b2t5dURQWmozSTlaanR4SDE0MkthMmxtc0lSNVNtbUN6ZWdxSVFSUERTM0NSYWI2enBHTVd2SDZWMEI0dFE5T3pGMnpCeExPeWtzd3M0aHR3ZVpyYkM5TjFtVFpFT1BXR2diQVU1UC1JamwxUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors", "summary": "LIXTE Biotechnology Holdings, Inc. is undergoing a strategic transformation to become an AI energy infrastructure equipment and services platform, aiming to address the escalating power demands of AI and hyperscale data centers. As part of this shift, Stuart D. Porter, founder of", "url": "https://www.theglobeandmail.com/investing/markets/stocks/LIXT-Q/pressreleases/36695718/lixte-biotechnology-announces-strategic-transformation-into-ai-energy-infrastructure-equipment-services-stuart-d-porter-founder-of-denham-capital-to-join-board-of-directors/", "source_name": "The Globe and Mail", "published_at": "2026-06-05T06:39:43", "published_display": "05 Jun 2026 06:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Raises $16.6 Million in Registered Direct Offering of Stock and Pre-Funded Warrants", "summary": "Lixte Biotechnology (LIXT) has completed a registered direct offering, raising approximately $16.6 million. The company sold 2,366,503 common shares at $6.31 each and issued pre-funded warrants for 258,859 shares at $6.30, with an exercise price of $0.0001. The offering closed on", "url": "https://www.tradingview.com/news/tradingview:55aec4647172b:0-lixte-biotechnology-raises-16-6-million-in-registered-direct-offering-of-stock-and-pre-funded-warrants/", "source_name": "TradingView", "published_at": "2026-06-04T20:39:34", "published_display": "04 Jun 2026 20:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte (NASDAQ: LIXT) closes $16.6M registered direct stock sale", "summary": "Lixte Biotechnology Holdings, Inc. has successfully closed a registered direct offering, raising approximately $16.6 million in gross proceeds. The offering included 2,366,503 shares of common stock and Pre-Funded Warrants for an additional 258,859 shares, priced at $6.31 per sha", "url": "https://www.stocktitan.net/sec-filings/LIXT/8-k-lixte-biotechnology-holdings-inc-reports-material-event-dc6e68ee44c8.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:39:34", "published_display": "04 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte (NASDAQ: LIXT) sells 2.37M shares and 258,859 pre-funded warrants for $16.6M", "summary": "Lixte Biotechnology Holdings, Inc. (LIXT) is conducting an equity offering of 2,366,503 shares of Common Stock and 258,859 Pre-Funded Warrants at a price of $6.31 each, aiming to raise approximately $16.57 million in gross proceeds. The company plans to use these proceeds for wor", "url": "https://www.stocktitan.net/sec-filings/LIXT/424b5-lixte-biotechnology-holdings-inc-prospectus-supplement-debt-sec-dee5a2dc215f.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:39:34", "published_display": "04 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth", "summary": "LIXTE Biotechnology Holdings, Inc. announced a registered direct offering of approximately $16.57 million through the sale of common stock and pre-funded warrants. This financing is intended to significantly strengthen the company's balance sheet, provide flexibility for strategi", "url": "https://www.globenewswire.com/news-release/2026/06/03/3306039/0/en/LIXTE-Biotechnology-Announces-16-566-027-Registered-Direct-Offering-Priced-at-the-Market-Under-Nasdaq-Rules-Strengthening-Balance-Sheet-for-Next-Phase-of-Strategic-Growth.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T04:09:20", "published_display": "04 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology raises $16.6 million in direct offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxORTdjMVRnQ3hyRnVJNTB4TW9obVkwbV84T1ZrSlN1dGtZSVRYNncwTE8zWVY2aE5lbFV1TzhqTDlvd0JDaWdhQTRqNHAtWWZvS0gyVFE0OWwwTEVoWFJocXhoWVAyLTlkd05MNlNiWVh2YnlwVGtOOC1ldXI0eWFLMllvaE9LeWVnN0NLbzF3alZ4cnIyNUYxa1JYS3lwSGMzcFRaYi04TFIxUWo1cXN3QkVKZDA?oc=5", "source_name": "Investing.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech LIXTE lines up $16.6M deal after Denham founder joins board", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPcEZNTWoySE5SVXdnQ25naDRKdnZxaVZ3VUZRc2ZNN0tSWEExMy1HbXo3aktqbmtzSll1R0VDcDNRNWhWdzJEV3JPVHdqT3hTNVFSaXpzYWZsR2R6Y2dPRUJjVlRKY21qdTdCWFNyRTNiUG1SV0NQNHp3RnowTXJkQXJxTVo4RHZXUW1zWFRuVmFOckJLdWpSLU5BU1QwOWZ4Qlo1ejlpZG9iLXNoWXpLNnRZNTFqLS1OczhMYmhKSQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology stock falls after $16.6M capital raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOWHBhMTJIQ0NfQjRmOWI1UlViaFd2OWpoNENCMVlOVG1vRUozbi1oSUtockIyVlNkUG5iODk4TnB5YWxzRjVfT0FVMzhtWkpVOEp0Mm1KUlNyaFl6NGdON2ZjWXFPRWY5YS1VQklhSzVEV2Q2cTNrcmlCdS1EZkFuem9jNkFLODNLa1BjcXdCdGlqcThhTUFHc08ybk9BeEVoTUZRSWZDVzNvd1A4eW9sLUN5TTZFMkFULVE?oc=5", "source_name": "Investing.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (LIXT) director receives 25,000 RSU equity grant", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQY1drdTBaN1ZqaXpxdmVBb3lRV2JxalRNZmphYmplcFd3WGJBbTZjV2J1WWJHaUMzcXZrdV9HbUFrZThiWHpOek93dHRxa1ZPeWktT2ZBQkJDN1NBc0k2aElxNkZkMWpYcVMyckFkOEw0MFVjbGw3LUVCS2tlNTJ3RExQVi02dzBXVGhnNDdUa0kzYWQyMzJQbFV4UEt1cktaNTBTVTRSLVlCU0FkMjB0cGN5cTJ1Rldka2Nnem9iV2dXdzBE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (Nasdaq: LIXT) targets AI power market, adds Denham Capital founder", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNbGdBSDBVWGt6UVpEcWVna2E0bExMNzRrVHFrNUoxSm9FcjRUQnJWbXV2c3dNeWNNd29XSHBwdnhMb2UwekZ0NVlPWXRtTkNZbWJnVmViT2liMW9CNnVUWTBSS0hGNVQzSEdybUdiTzIwUmFON0VVSk13MVVKV0c0dGViRkZCQ1RqeEhPcE1hYjJvMTNWWWRYdDA2R05CWUp6b185TVZlLWR2eXdkR0pwcHh1ZEs4d3FTaE5DN2N3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cancer-drug developer LIXTE retools to power AI-hungry data centers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQcXhlVk41UWphUC1LRjRKR2NBemZ2MGcxWnR6TGJZb1BUU21WTG1icS1vVW1ZU0JjbWdfeEhlMlM0UkpJekI3N2psUmUwanZBYUtDQTVwMGgwTnF4ZGQxMVhfNlZrOGtZclVUZWxnZnpTclo1TGRNS1U2ampfcDFlRENfaDVJdEZaTW9kQ2tqdm5KbnhWVlZlUThoaVN1cHBuQ0ZZRW1ObW9QNVEzLWRNRHplQ3MxUkpU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (LIXT) director Stuart D Porter files Form 3 with no trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQb2hkYi1YN0Qzc3BVUFVxNXNtSGF1SU40RmU3MUducG0wb2ZLREg5UVBpTkNhWG95OTJIN1U4XzJNelE4WnpucDVaVGhWb0U2MTVoeHJIWVBTWUl0VDNyVXdRZ0k2UVhVcUUyQWtzTTNMOVRLZ25RT25qNXptMUgzRnRmMTlVd1gyTHI4UXJPQ3VvbVE2WDhDQmNla3lVMzVkZ1lVYjkwdEdPZ1VrWkJ2Z2xxSTZzYmJ2cFBTQjU5eEMtclpSdUZPZmtTcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-files-first-quarter-211800838.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T21:18:00+00:00", "published_display": "14 May 2026 21:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: PDS Biotechnology beats Q1 2026 EPS expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUTY4SzBROHBQYlRIT2Y0U2NWN1NHN0hlSkJHNXZMamhvN1dpRWVpNlZKb3I4UDAtOVZRS2dqNzRiTWZISUtTdlZVbldnZ3pfV1N0VXh0NWV0ckpMcUZGRDdaZGlXSEFZWktvdHVreUladmplcUJXLUpMYUxpMVBIOEJWSlJodnJhZjBHMlN6dF8zVUlRWHlHblFQZ3dNa1FWUDJ4eVVNMWVZZ0dVaWtsZEhBcTB2bFNROXE3VXFYQ3NJWXIxYjRYZw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDS Biotechnology Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTXNUdVZadGlGUFRyY004aWwyQUQ1eUhVLVRxbUJtWTVrSndNdFV0S0xJYjdPTlhUVmNxVDl3Q2Y4VnE0d280bDh3QlFOOUNHS2JtRExnX0FfWHozeUNKVDhpRjJLbHZjdHdEQ0hldlRZbTFKdVNqWFEzRlFCbkNOclYweTJCcnNvXzFXWWVRWEhnSXVPbVJwSUJSbldKQlFXUF8zOTdKYlRxUQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sana Biotechnology\u2019s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q1 Adjusted Loss $0.14 per Share, vs. FactSet Est of $-0.16", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxORXhXX1dvLWtkbEVlWjV3WHF0Y3RVQ192c0ZzVnZ6SnRJbzI1Ump5Y0lyM2htVXhwUlBtODdwdkRtRWNxU1dyLUdoa004S21MQ0JJMHZ3ZjRzLXRvTWM2Mmtka2toV0ZVblJPb3JCRkFQUGM2VldyVDF4dWh1VU9DUXhwUEhoWTY2M0FJd2lndHREWkUxMHFtVWs2WHBWT3hyYVQ1SkdlVTJ4N1lwTkxvOHlLa01neFl1VWRWSWd2YXRsajZvTEYwNzBaVVhuVnp1VW1KdV9oNjVabzVDbnNR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Holdings (LIXT) Unlocking New Potential in Precision Cancer Treatment", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-holdings-lixt-unlocking-181451161.html", "source_name": "NewMediaWire", "published_at": "2026-04-27T18:14:51+00:00", "published_display": "27 Apr 2026 18:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-holdings-lixt-positions-190000106.html", "source_name": "NewMediaWire", "published_at": "2026-04-20T19:00:00+00:00", "published_display": "20 Apr 2026 19:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-lixt-reports-interim-193000039.html", "source_name": "NewMediaWire", "published_at": "2026-04-13T19:30:00+00:00", "published_display": "13 Apr 2026 19:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "These Stocks Are Today\u2019s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1TVVFUSGtfSXRkeXd1YUFxTmRYXzJtLVRnaUh6M053UjQtbkNZR3VKOF81RnN3bHY2UmRvMVdRWG1QSVlmS1Q1UUo3bmxSVnpoMGNEZFRVWThJdFVpNTU2dFgtX2I?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOTlBxUW9QV2o3YTF4RVdzWWlWUWZfU2V6Y25mcHBxM2RQTkpES0FqY0xsRDdtc0NqZE1KY2RFSWFfMGVCSVR2RXpndERPOFF6al9HQndCU2p0SkpPQ3dsc19BaVVvSzFxQ2FwcGEwVFlxNUFmZUUtdHpvVmpfQkFDX2FVLXprUQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "LIXTE to loan $6.5M to NOMAD ahead of acquisition close", "summary": "LIXTE Biotechnology Holdings, Inc. announced it will loan $6.5 million to NOMAD Transportable Power Systems prior to their acquisition closing, expected around July 1, 2026. This loan will help fund procurement and working capital for NOMAD, a company specializing in deployable b", "url": "https://www.investing.com/news/company-news/lixte-to-loan-65m-to-nomad-ahead-of-acquisition-close-93CH-4749907", "source_name": "Investing.com", "published_at": "2026-06-19T10:11:19", "published_display": "19 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026", "summary": "LIXTE Biotechnology Holdings, Inc. has provided an update on its acquisition of NOMAD Transportable Power Systems, Inc., a deal expected to close around July 1, 2026. LIXTE will loan NOMAD $6.5 million to fund its order backlog and working capital needs before closing, aiming to ", "url": "https://www.marketscreener.com/news/lixte-biotechnology-provides-update-on-nomad-acquisition-transaction-expected-to-close-on-or-about-ce7f5cdddf80f224", "source_name": "www.marketscreener.com", "published_at": "2026-06-19T10:09:12", "published_display": "19 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE loans NOMAD $6.5M before power-storage deal closes", "summary": "LIXTE Biotechnology has provided a pre-closing loan of $6.5 million to NOMAD Transportable Power Systems to fund its order backlog and working capital as the acquisition is expected to close around July 1, 2026. Upon completion, LIXTE will be renamed NOMAD Power Solutions and tra", "url": "https://www.stocktitan.net/news/LIXT/lixte-biotechnology-provides-update-on-nomad-acquisition-transaction-xq2mbfb4dp53.html", "source_name": "Stock Titan", "published_at": "2026-06-18T22:09:57", "published_display": "18 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings, Inc. (LIXTW) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1pUXFMTVFJSTBqLTVpSXJNY1pqSU9CSUFqeFRyOFkwZE80dE5VNUtJODFPWDl3OHpBYUprVDlEbnAzdE10b0std241N3VHX2JtQ0NZ?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-06-18T20:03:33+00:00", "published_display": "18 Jun 2026 20:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (NASDAQ: LIXT) funds NOMAD with $6.5M secured bridge loan", "summary": "LIXTE Biotechnology Holdings, Inc. provided NOMAD Transportable Power Systems with a $6.5 million secured bridge loan ahead of their planned acquisition, expected to close around July 1, 2026. The loan will help NOMAD repay existing debt and fund working capital to meet its activ", "url": "https://www.stocktitan.net/sec-filings/LIXT/8-k-lixte-biotechnology-holdings-inc-reports-material-event-783875ee424a.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:10:26", "published_display": "18 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Provides $6.5 Million Secured Note to NOMAD Ahead of Planned Merger", "summary": "Lixte Biotechnology has provided a $6.5 million secured promissory note to NOMAD Transportable Power Systems in anticipation of their upcoming merger. These funds will be used to repay NOMAD's existing loan and cover working capital needs. The note, secured by NOMAD's assets, has", "url": "https://www.tradingview.com/news/tradingview:e6fdf0c6e90cd:0-lixte-biotechnology-provides-6-5-million-secured-note-to-nomad-ahead-of-planned-merger/", "source_name": "TradingView", "published_at": "2026-06-18T20:10:26", "published_display": "18 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Nasdaq Company Just Reinvented Itself as a Power Company \u2014 and Bet It All on the AI Energy Crunch", "summary": "LIXTE Biotechnology Holdings (NASDAQ: LIXT) is transforming into NOMAD Power Solutions, a pure-play deployable power company, by combining with NOMAD Transportable Power Systems. This strategic shift addresses the critical electricity bottleneck facing the AI industry, with LIXTE", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314363/0/en/a-nasdaq-company-just-reinvented-itself-as-a-power-company-and-bet-it-all-on-the-ai-energy-crunch.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T15:10:26", "published_display": "18 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The AI Boom\u2019s Real Bottleneck Is Power \u2014 and One Nasdaq Company Is Reinventing Itself to Solve It", "summary": "LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) is transforming into NOMAD Power Solutions, a pure-play deployable-power company, via a merger with NOMAD Transportable Power Systems. This strategic shift aims to address the significant power demands of the AI industry, which ha", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314267/0/en/the-ai-boom-s-real-bottleneck-is-power-and-one-nasdaq-company-is-reinventing-itself-to-solve-it.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T13:10:26", "published_display": "18 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Lixte Biotechnology Holdings Inc (LIXT), including its current price momentum score, support and resistance levels. It details various technical indicators like MACD, RSI, and moving averages, offering buy, sell, or neutral signals. T", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/technical", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:26", "published_display": "18 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Institutional Confidence", "summary": "Lixte Biotechnology Holdings Inc (LIXT) has an institutional shareholding score of 3.00, placing it 193rd out of 388 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 8.14%, reflecting a 4.01% decrease quarter-over-quarter. Jame", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T06:10:04", "published_display": "18 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Lixte Biotechnology Holdings Inc (LIXT), indicating that no earnings forecast score is currently available for the company. It notes the Biotechnology & Medical Research industry's average score is 8.13 and states that relevant financ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T05:10:05", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Lixte Biotechnology Holdings Inc (LIXT), noting its current valuation score of 6.61 and its ranking within the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -6.07, and states that relevant data fo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixt/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T05:10:05", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFAzeFlLY1JSWjNDLUI5OG9yMThjZ1dKT1ZIZDZIS292cW5XUTFMaFlVZWJLQjhCTkZZWll6bmNlQzNFOE1tbUx1RHVQX0pkaVV3b1plM2tuUThVYzZsOS1GZjdma3RZTlVqVXdSVWc1VkluMEVjbmtv?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T02:20:24+00:00", "published_display": "18 Jun 2026 02:20", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXT) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5icVZSQWVLWDg3RFMzZnlMcHpraTExaF80VU1MRFpRWURYdXBnQ2JrTVV2eC1qS0Y1b21UYmVPT3h3dnV1cEtGT0xqRVFrTDNBc21qa1ExTjBZWFB4QjRqRWtxcTZxX2MtSHRlSmZEX0NOdkpWaFp5LQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:52:43+00:00", "published_display": "17 Jun 2026 21:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of dividend and stock split history for Lixte Biotechnology Holdings Inc (LIXTW). It indicates that the company has distributed a total of $0.00 in dividends over the past five years and has no recorded stock split data. The page serves as a fina", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T06:41:59", "published_display": "17 Jun 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc", "summary": "This article provides an overview of Lixte Biotechnology Holdings Inc. (LIXTW), noting that relevant data regarding its revenue breakdown by business segments and regions have not yet been disclosed by the company. The page displays the current stock price and highlights that fin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T05:40:40", "published_display": "17 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides a detailed look into the shareholder structure of Lixte Biotechnology Holdings Inc (LIXTW), focusing on institutional holdings and recent shareholder activity. It presents data on the number of institutions holding shares, the total shares held, and changes ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T05:40:40", "published_display": "17 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology to Acquire Nomad Transportable Power Systems in Stock Deal of Up to 53.5M Shares", "summary": "Lixte Biotechnology has entered into a Merger Agreement to acquire Nomad Transportable Power Systems through a stock-for-stock transaction. Nomad shareholders are set to receive up to 50.5 million common shares via Series D Convertible Preferred Stock and an additional 3.0 millio", "url": "https://www.tradingview.com/news/tradingview:f784e608344df:0-lixte-biotechnology-to-acquire-nomad-transportable-power-systems-in-stock-deal-of-up-to-53-5m-shares/", "source_name": "TradingView", "published_at": "2026-06-16T20:03:16", "published_display": "16 Jun 2026 20:03", "sentiment": "positive", "sentiment_pct": 69, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (NASDAQ: LIXT) to buy NOMAD and pivot into mobile grid-scale BESS", "summary": "LIXTE Biotechnology Holdings, Inc. has entered into a definitive merger agreement to acquire 100% of NOMAD Transportable Power Systems, a leader in mobile battery energy storage systems, and will be renamed NOMAD Power Solutions. This strategic acquisition shifts LIXTE from a cli", "url": "https://www.stocktitan.net/sec-filings/LIXT/8-k-lixte-biotechnology-holdings-inc-reports-material-event-346afb8b9eb5.html", "source_name": "Stock Titan", "published_at": "2026-06-16T19:59:16", "published_display": "16 Jun 2026 19:59", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Lixte Biotechnology Holdings Inc (LIXTW), focusing on key indicators and moving averages. It highlights that while multiple indicators suggest \"Sell\" or \"Oversold\" signals, some moving averages (MA5, MA10) show \"Buy\" signals. The arti", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/technical", "source_name": "TradingKey", "published_at": "2026-06-16T14:39:17", "published_display": "16 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Holdings Inc (LIXTW) Institutional Confidence", "summary": "The article provides an overview of Lixte Biotechnology Holdings Inc (LIXTW), focusing on its institutional confidence score and shareholder activity. It lists several institutional holders and the changes in their shareholdings, with many showing a 100% decrease. The institution", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lixtw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T14:39:16", "published_display": "16 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The New Bottleneck Isn\u2019t Computing Power \u2014 It\u2019s Just Power", "summary": "The AI boom's new bottleneck is not computing power but the availability of electricity, as building data centers outpaces the grid's ability to deliver power. LIXTE Biotechnology Holdings, Inc. is repositioning itself to address this challenge by acquiring NOMAD Transportable Po", "url": "https://www.theglobeandmail.com/investing/markets/stocks/FLNC/pressreleases/2451956/the-new-bottleneck-isnt-computing-power-its-just-power/", "source_name": "The Globe and Mail", "published_at": "2026-06-13T07:40:56", "published_display": "13 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch", "summary": "LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT), previously a clinical-stage cancer-drug developer, is undergoing a complete corporate transformation to become a pure-play power-infrastructure company. This strategic shift involves the acquisition of NOMAD Transportable Power S", "url": "https://www.sahmcapital.com/news/content/from-cancer-drugs-to-kilowatts-a-nasdaq-companys-bet-on-the-ai-power-crunch-2026-06-12", "source_name": "Sahm", "published_at": "2026-06-12T20:41:59", "published_display": "12 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)", "summary": "", "url": "https://finance.yahoo.com/sectors/energy/articles/lixte-biotechnology-acquire-nomad-transportable-123000285.html", "source_name": "GlobeNewswire", "published_at": "2026-06-12T12:30:00+00:00", "published_display": "12 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mobile grid batteries for AI boom: LIXTE to acquire NOMAD BESS leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNc0QxM0x3TG5ZbDUzVDI5LXFmVnZyWUxGd25MZjFXWEhDWmtpdEUxYURfOWJEZ1VWVEhhVHVKR3EwNTA5QzZFcUtFdHZ0VDJTNi1iQU4zVHpNVW84d045YlliQkp1cTYyWDdicnAxVGdjY1h4d0RCSUs1cUdNZEFMMGgybkQtSXg4V2swZFF5SjBFNk9TczNLUHE2bGpLWE1hXzhrYmFlb2doZTVSWm5oOWVTWi04SmxfWWcyMlg5NWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T12:30:00+00:00", "published_display": "12 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE to acquire NOMAD Transportable Power Systems for BESS pivot", "summary": "LIXTE Biotechnology (NASDAQ:LIXT) is strategically transforming its business by acquiring NOMAD Transportable Power Systems. This acquisition marks a pivot from its oncology pipeline to become a platform for AI and utility energy infrastructure, addressing critical bottlenecks in", "url": "https://grafa.com/en/news/united-states/lixte-biotechnology-nomad-power-acquisition", "source_name": "grafa.com", "published_at": "2026-06-12T08:09:10", "published_display": "12 Jun 2026 08:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G] LIXTE BIOTECHNOLOGY HOLDINGS, INC. Passive Investment Disclosure (>5%)", "summary": "This SEC filing (Schedule 13G) discloses that Strategic EP, LLC and Alexander Chase Deitch have acquired beneficial ownership of 5.1% of LIXTE BIOTECHNOLOGY HOLDINGS, INC. common stock. The filing states that Strategic EP, LLC and Alexander Chase Deitch collectively own 774,902 s", "url": "https://www.stocktitan.net/sec-filings/LIXT/schedule-13g-lixte-biotechnology-holdings-inc-passive-investment-disc-14e8ee164895.html", "source_name": "Stock Titan", "published_at": "2026-06-09T23:40:18", "published_display": "09 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology (NASDAQ:LIXT) holders report 5.1% stake in company", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOVEswMzZvV3FDVllWS1ZhbDNHX2N5bTh6cmRieXM5R3pKNDI2WWpvRnI4MlNyckwyVTk1bE1ySXdWYVN0S1NrRkVPek5zbDBHUmd0ajUwNXlvZ1JRMG91b2t5dURQWmozSTlaanR4SDE0MkthMmxtc0lSNVNtbUN6ZWdxSVFSUERTM0NSYWI2enBHTVd2SDZWMEI0dFE5T3pGMnpCeExPeWtzd3M0aHR3ZVpyYkM5TjFtVFpFT1BXR2diQVU1UC1JamwxUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors", "summary": "LIXTE Biotechnology Holdings, Inc. is undergoing a strategic transformation to become an AI energy infrastructure equipment and services platform, aiming to address the escalating power demands of AI and hyperscale data centers. As part of this shift, Stuart D. Porter, founder of", "url": "https://www.theglobeandmail.com/investing/markets/stocks/LIXT-Q/pressreleases/36695718/lixte-biotechnology-announces-strategic-transformation-into-ai-energy-infrastructure-equipment-services-stuart-d-porter-founder-of-denham-capital-to-join-board-of-directors/", "source_name": "The Globe and Mail", "published_at": "2026-06-05T06:39:43", "published_display": "05 Jun 2026 06:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology Raises $16.6 Million in Registered Direct Offering of Stock and Pre-Funded Warrants", "summary": "Lixte Biotechnology (LIXT) has completed a registered direct offering, raising approximately $16.6 million. The company sold 2,366,503 common shares at $6.31 each and issued pre-funded warrants for 258,859 shares at $6.30, with an exercise price of $0.0001. The offering closed on", "url": "https://www.tradingview.com/news/tradingview:55aec4647172b:0-lixte-biotechnology-raises-16-6-million-in-registered-direct-offering-of-stock-and-pre-funded-warrants/", "source_name": "TradingView", "published_at": "2026-06-04T20:39:34", "published_display": "04 Jun 2026 20:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte (NASDAQ: LIXT) closes $16.6M registered direct stock sale", "summary": "Lixte Biotechnology Holdings, Inc. has successfully closed a registered direct offering, raising approximately $16.6 million in gross proceeds. The offering included 2,366,503 shares of common stock and Pre-Funded Warrants for an additional 258,859 shares, priced at $6.31 per sha", "url": "https://www.stocktitan.net/sec-filings/LIXT/8-k-lixte-biotechnology-holdings-inc-reports-material-event-dc6e68ee44c8.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:39:34", "published_display": "04 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte (NASDAQ: LIXT) sells 2.37M shares and 258,859 pre-funded warrants for $16.6M", "summary": "Lixte Biotechnology Holdings, Inc. (LIXT) is conducting an equity offering of 2,366,503 shares of Common Stock and 258,859 Pre-Funded Warrants at a price of $6.31 each, aiming to raise approximately $16.57 million in gross proceeds. The company plans to use these proceeds for wor", "url": "https://www.stocktitan.net/sec-filings/LIXT/424b5-lixte-biotechnology-holdings-inc-prospectus-supplement-debt-sec-dee5a2dc215f.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:39:34", "published_display": "04 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth", "summary": "LIXTE Biotechnology Holdings, Inc. announced a registered direct offering of approximately $16.57 million through the sale of common stock and pre-funded warrants. This financing is intended to significantly strengthen the company's balance sheet, provide flexibility for strategi", "url": "https://www.globenewswire.com/news-release/2026/06/03/3306039/0/en/LIXTE-Biotechnology-Announces-16-566-027-Registered-Direct-Offering-Priced-at-the-Market-Under-Nasdaq-Rules-Strengthening-Balance-Sheet-for-Next-Phase-of-Strategic-Growth.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T04:09:20", "published_display": "04 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology raises $16.6 million in direct offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxORTdjMVRnQ3hyRnVJNTB4TW9obVkwbV84T1ZrSlN1dGtZSVRYNncwTE8zWVY2aE5lbFV1TzhqTDlvd0JDaWdhQTRqNHAtWWZvS0gyVFE0OWwwTEVoWFJocXhoWVAyLTlkd05MNlNiWVh2YnlwVGtOOC1ldXI0eWFLMllvaE9LeWVnN0NLbzF3alZ4cnIyNUYxa1JYS3lwSGMzcFRaYi04TFIxUWo1cXN3QkVKZDA?oc=5", "source_name": "Investing.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech LIXTE lines up $16.6M deal after Denham founder joins board", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPcEZNTWoySE5SVXdnQ25naDRKdnZxaVZ3VUZRc2ZNN0tSWEExMy1HbXo3aktqbmtzSll1R0VDcDNRNWhWdzJEV3JPVHdqT3hTNVFSaXpzYWZsR2R6Y2dPRUJjVlRKY21qdTdCWFNyRTNiUG1SV0NQNHp3RnowTXJkQXJxTVo4RHZXUW1zWFRuVmFOckJLdWpSLU5BU1QwOWZ4Qlo1ejlpZG9iLXNoWXpLNnRZNTFqLS1OczhMYmhKSQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lixte Biotechnology stock falls after $16.6M capital raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOWHBhMTJIQ0NfQjRmOWI1UlViaFd2OWpoNENCMVlOVG1vRUozbi1oSUtockIyVlNkUG5iODk4TnB5YWxzRjVfT0FVMzhtWkpVOEp0Mm1KUlNyaFl6NGdON2ZjWXFPRWY5YS1VQklhSzVEV2Q2cTNrcmlCdS1EZkFuem9jNkFLODNLa1BjcXdCdGlqcThhTUFHc08ybk9BeEVoTUZRSWZDVzNvd1A4eW9sLUN5TTZFMkFULVE?oc=5", "source_name": "Investing.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (LIXT) director receives 25,000 RSU equity grant", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQY1drdTBaN1ZqaXpxdmVBb3lRV2JxalRNZmphYmplcFd3WGJBbTZjV2J1WWJHaUMzcXZrdV9HbUFrZThiWHpOek93dHRxa1ZPeWktT2ZBQkJDN1NBc0k2aElxNkZkMWpYcVMyckFkOEw0MFVjbGw3LUVCS2tlNTJ3RExQVi02dzBXVGhnNDdUa0kzYWQyMzJQbFV4UEt1cktaNTBTVTRSLVlCU0FkMjB0cGN5cTJ1Rldka2Nnem9iV2dXdzBE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (Nasdaq: LIXT) targets AI power market, adds Denham Capital founder", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNbGdBSDBVWGt6UVpEcWVna2E0bExMNzRrVHFrNUoxSm9FcjRUQnJWbXV2c3dNeWNNd29XSHBwdnhMb2UwekZ0NVlPWXRtTkNZbWJnVmViT2liMW9CNnVUWTBSS0hGNVQzSEdybUdiTzIwUmFON0VVSk13MVVKV0c0dGViRkZCQ1RqeEhPcE1hYjJvMTNWWWRYdDA2R05CWUp6b185TVZlLWR2eXdkR0pwcHh1ZEs4d3FTaE5DN2N3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cancer-drug developer LIXTE retools to power AI-hungry data centers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQcXhlVk41UWphUC1LRjRKR2NBemZ2MGcxWnR6TGJZb1BUU21WTG1icS1vVW1ZU0JjbWdfeEhlMlM0UkpJekI3N2psUmUwanZBYUtDQTVwMGgwTnF4ZGQxMVhfNlZrOGtZclVUZWxnZnpTclo1TGRNS1U2ampfcDFlRENfaDVJdEZaTW9kQ2tqdm5KbnhWVlZlUThoaVN1cHBuQ0ZZRW1ObW9QNVEzLWRNRHplQ3MxUkpU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE (LIXT) director Stuart D Porter files Form 3 with no trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQb2hkYi1YN0Qzc3BVUFVxNXNtSGF1SU40RmU3MUducG0wb2ZLREg5UVBpTkNhWG95OTJIN1U4XzJNelE4WnpucDVaVGhWb0U2MTVoeHJIWVBTWUl0VDNyVXdRZ0k2UVhVcUUyQWtzTTNMOVRLZ25RT25qNXptMUgzRnRmMTlVd1gyTHI4UXJPQ3VvbVE2WDhDQmNla3lVMzVkZ1lVYjkwdEdPZ1VrWkJ2Z2xxSTZzYmJ2cFBTQjU5eEMtclpSdUZPZmtTcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-files-first-quarter-211800838.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T21:18:00+00:00", "published_display": "14 May 2026 21:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: PDS Biotechnology beats Q1 2026 EPS expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUTY4SzBROHBQYlRIT2Y0U2NWN1NHN0hlSkJHNXZMamhvN1dpRWVpNlZKb3I4UDAtOVZRS2dqNzRiTWZISUtTdlZVbldnZ3pfV1N0VXh0NWV0ckpMcUZGRDdaZGlXSEFZWktvdHVreUladmplcUJXLUpMYUxpMVBIOEJWSlJodnJhZjBHMlN6dF8zVUlRWHlHblFQZ3dNa1FWUDJ4eVVNMWVZZ0dVaWtsZEhBcTB2bFNROXE3VXFYQ3NJWXIxYjRYZw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDS Biotechnology Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTXNUdVZadGlGUFRyY004aWwyQUQ1eUhVLVRxbUJtWTVrSndNdFV0S0xJYjdPTlhUVmNxVDl3Q2Y4VnE0d280bDh3QlFOOUNHS2JtRExnX0FfWHozeUNKVDhpRjJLbHZjdHdEQ0hldlRZbTFKdVNqWFEzRlFCbkNOclYweTJCcnNvXzFXWWVRWEhnSXVPbVJwSUJSbldKQlFXUF8zOTdKYlRxUQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sana Biotechnology\u2019s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q1 Adjusted Loss $0.14 per Share, vs. FactSet Est of $-0.16", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxORXhXX1dvLWtkbEVlWjV3WHF0Y3RVQ192c0ZzVnZ6SnRJbzI1Ump5Y0lyM2htVXhwUlBtODdwdkRtRWNxU1dyLUdoa004S21MQ0JJMHZ3ZjRzLXRvTWM2Mmtka2toV0ZVblJPb3JCRkFQUGM2VldyVDF4dWh1VU9DUXhwUEhoWTY2M0FJd2lndHREWkUxMHFtVWs2WHBWT3hyYVQ1SkdlVTJ4N1lwTkxvOHlLa01neFl1VWRWSWd2YXRsajZvTEYwNzBaVVhuVnp1VW1KdV9oNjVabzVDbnNR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQajdOSHprODFDWnVnMjZqMnc2Ynp0dEx2aHhSWV80dWtmRHU1Und5ZDJvRDZ1c1IyalhpYXo4UVlOVmNzdWoxS21JM0psajA4OTRnZFptOVVOYnYwaXRMYjNvdzZZRURoRmpnbGtsbGxsa0pIdjRmWUw2MjdyN2Rzb3JTb3BtTl9RLXJzM0QzYzF2cURTNW5PYXhISkNEeTZMZ3RkN3pyMTByZ3hVcEk4djYwSmVIUi1TZWJia2UtYXc3TDFja2lDY0pDLTRtX0xGX0lsV2VVZHNRU0hqTVNDX3VtZWjSAeoBQVVfeXFMTVd2bDZNajBqZV9rSlR0Mkc3bzdVMXFwa3hTcmY3SGhTNmQ2VTZ5Y29Iek81RTZYZGs5SkRTeG5RbXoxUmQwd04xSG1uOXVZMDVPMlZ0MGozTXpHOV9adGV6SnZZMzhsX3RObnJKRWcwSGVsVXBrdmpTTzBTV0txb2xmNWllVGR2UFV2MmV6S3JOcTFZbVc5SklqQi1wNVVoelRCb25pZHNvR0NyNVcxbU5UeGM0UVVlTmR0d0Rha3BnbzV1SzU3NWFyMzBIclBpd3hvRjhaeDcwTWNqWHpWNzFMX0l2NEsybjln?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Holdings (LIXT) Unlocking New Potential in Precision Cancer Treatment", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-holdings-lixt-unlocking-181451161.html", "source_name": "NewMediaWire", "published_at": "2026-04-27T18:14:51+00:00", "published_display": "27 Apr 2026 18:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-holdings-lixt-positions-190000106.html", "source_name": "NewMediaWire", "published_at": "2026-04-20T19:00:00+00:00", "published_display": "20 Apr 2026 19:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lixte-biotechnology-lixt-reports-interim-193000039.html", "source_name": "NewMediaWire", "published_at": "2026-04-13T19:30:00+00:00", "published_display": "13 Apr 2026 19:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "These Stocks Are Today\u2019s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1TVVFUSGtfSXRkeXd1YUFxTmRYXzJtLVRnaUh6M053UjQtbkNZR3VKOF81RnN3bHY2UmRvMVdRWG1QSVlmS1Q1UUo3bmxSVnpoMGNEZFRVWThJdFVpNTU2dFgtX2I?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOTlBxUW9QV2o3YTF4RVdzWWlWUWZfU2V6Y25mcHBxM2RQTkpES0FqY0xsRDdtc0NqZE1KY2RFSWFfMGVCSVR2RXpndERPOFF6al9HQndCU2p0SkpPQ3dsc19BaVVvSzFxQ2FwcGEwVFlxNUFmZUUtdHpvVmpfQkFDX2FVLXprUQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 91, "total_relevant": 63, "sentiment_summary": {"positive": 19, "negative": 5, "neutral": 39, "score": 55, "total": 63, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 17.95, "count": 32}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 18}, {"event": "deals", "label": "Deals and strategy", "weight": 6.6, "count": 12}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 19, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 7.61, "latest_week": "2026-06-19", "one_week_move": 22.9, "four_week_move": 29.4, "twelve_week_move": 146.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.451925, "market_dynamics_buy_signal": false, "relative_strength": 53.20422, "fair_value_gap": 163.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 37.1531, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+22.9% over one week, +29.4% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 13}, {"label": "TradingKey", "count": 11}, {"label": "Market source", "count": 6}, {"label": "GlobeNewswire", "count": 5}, {"label": "Investing.com", "count": 4}, {"label": "TradingView", "count": 4}, {"label": "simplywall.st", "count": 3}, {"label": "NewMediaWire", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 63}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 32}, {"label": "Earnings", "count": 18}, {"label": "Deals and strategy", "count": 12}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "63", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+22.9% over one week, +29.4% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "LIXTE to loan $6.5M to NOMAD ahead of acquisition close"}], "updated_at": "2026-06-23T02:17:07.678023+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}